Morgan Stanley Increases Hamilton Lane (NASDAQ:HLNE) Price Target to $190.00

Hamilton Lane (NASDAQ:HLNEGet Free Report) had its price objective lifted by investment analysts at Morgan Stanley from $182.00 to $190.00 in a report issued on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price target suggests a potential downside of 3.50% from the stock’s previous close.

Other research analysts have also recently issued research reports about the stock. Keefe, Bruyette & Woods upped their price target on shares of Hamilton Lane from $181.00 to $215.00 and gave the stock a “market perform” rating in a report on Thursday, November 7th. JPMorgan Chase & Co. boosted their target price on Hamilton Lane from $134.00 to $175.00 and gave the stock a “neutral” rating in a research report on Thursday, November 7th. The Goldman Sachs Group raised their price target on Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a report on Thursday, October 3rd. Wells Fargo & Company boosted their price objective on Hamilton Lane from $156.00 to $170.00 and gave the stock an “equal weight” rating in a report on Wednesday, October 9th. Finally, UBS Group lifted their target price on shares of Hamilton Lane from $150.00 to $185.00 and gave the company a “neutral” rating in a research report on Tuesday, October 22nd. Seven equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Hamilton Lane has a consensus rating of “Hold” and a consensus target price of $180.33.

Read Our Latest Research Report on Hamilton Lane

Hamilton Lane Trading Down 2.3 %

NASDAQ:HLNE opened at $196.90 on Monday. The company has a market cap of $10.67 billion, a P/E ratio of 42.71 and a beta of 1.18. Hamilton Lane has a 1 year low of $89.38 and a 1 year high of $203.72. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.37 and a quick ratio of 2.72. The stock’s fifty day moving average price is $171.18 and its two-hundred day moving average price is $144.19.

Hamilton Lane (NASDAQ:HLNEGet Free Report) last issued its earnings results on Wednesday, November 6th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.06 by $0.01. Hamilton Lane had a return on equity of 35.59% and a net margin of 28.03%. The business had revenue of $150.00 million during the quarter, compared to the consensus estimate of $151.55 million. During the same quarter last year, the company earned $0.89 EPS. The firm’s revenue was up 18.2% compared to the same quarter last year. As a group, analysts expect that Hamilton Lane will post 4.89 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Covestor Ltd boosted its holdings in Hamilton Lane by 14,900.0% during the 1st quarter. Covestor Ltd now owns 300 shares of the company’s stock valued at $34,000 after acquiring an additional 298 shares during the period. Quarry LP grew its holdings in shares of Hamilton Lane by 316.2% in the second quarter. Quarry LP now owns 308 shares of the company’s stock worth $38,000 after purchasing an additional 234 shares during the last quarter. Signaturefd LLC increased its stake in shares of Hamilton Lane by 13.1% in the second quarter. Signaturefd LLC now owns 629 shares of the company’s stock worth $78,000 after buying an additional 73 shares during the period. CWM LLC raised its holdings in Hamilton Lane by 24.7% during the 3rd quarter. CWM LLC now owns 505 shares of the company’s stock valued at $85,000 after buying an additional 100 shares during the last quarter. Finally, Fifth Third Bancorp boosted its position in Hamilton Lane by 106.5% during the 2nd quarter. Fifth Third Bancorp now owns 694 shares of the company’s stock valued at $86,000 after buying an additional 358 shares during the period. Hedge funds and other institutional investors own 97.40% of the company’s stock.

About Hamilton Lane

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Further Reading

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

Receive News & Ratings for Hamilton Lane Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Lane and related companies with MarketBeat.com's FREE daily email newsletter.